Watson Shelly H, Shekhawat Nakul S, Daoud Yassine J
Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA.
Am J Ophthalmol Case Rep. 2022 Jan 22;25:101330. doi: 10.1016/j.ajoc.2022.101330. eCollection 2022 Mar.
To describe a case of recalcitrant Acanthamoeba Keratitis (AK) complicated by medical non-compliance and medication intolerance that was successfully treated with photoactivated chromophore for infectious keratitis corneal collagen cross-linking (PACK-CXL).
A 31-year-old male presented with right eye pain and redness in the setting of fresh water exposure and scleral contact lens wear. He had lack of a response to treatment with antiviral therapy for 3 months by an outside provider. Cultures were found to be positive for and the patient was treated with an extended course of various anti-amoebic therapies with poor compliance due to pain and toxicity. He was eventually treated with intrastromal voriconazole and Miltefosine without improvement and eventually had PACK-CXL with resolution of his infection and pain.
PACK-CXL was associated with a dramatic improvement in a case of recalcitrant keratitis unresponsive to both traditional and novel therapies and may be a viable alternative or adjunctive therapy for keratitis.
描述一例难治性棘阿米巴角膜炎(AK)病例,该病例因患者不遵医嘱及药物不耐受而复杂化,最终通过用于感染性角膜炎角膜胶原交联的光活化发色团(PACK-CXL)成功治疗。
一名31岁男性在接触淡水和佩戴巩膜接触镜后出现右眼疼痛和发红。外部医疗机构对其进行抗病毒治疗3个月,未见疗效。培养结果显示 呈阳性,患者接受了多种抗阿米巴治疗的延长疗程,但由于疼痛和毒性,患者依从性差。他最终接受了基质内伏立康唑和米替福新治疗,但病情未改善,最终通过PACK-CXL治疗,感染和疼痛得以缓解。
在一例对传统和新型疗法均无反应的难治性角膜炎病例中,PACK-CXL带来了显著改善,可能是棘阿米巴角膜炎的一种可行替代或辅助治疗方法。